Better Homes And Gardens 2010 10, page 279 read online

A new dosing option for your loved one

ARICEPT® 23 mg/day is now FDA approved for moderate to severe Alzheimer’s disease.

Ask the doctor about new ARICEPT 23 mg/day.

ARICEPT (donepezil HCI) is a prescription medicine to treat mild Alzheimer’s disease (up to 10 mg/day) and

moderate to severe Alzheimer’s disease (up to 23 mg/day).

Before starting on ARICEPT 23 mg/day, patients should be on ARICEPT 10 mg/day for at least 3 months. The

starting dose of ARICEPT is 5 mg/day and can be increased to 10 mg/day after 4-6 weeks. Please take ARICEPT

as prescribed by the doctor.

IMPORTANT SAFETY INFORMATION

ARICEPT® may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should

tell their doctors because serious stomach problems, such as bleeding, may get worse.

People at risk for certain heart conditions should tell their doctor before starting ARICEPT because they may

experience fainting. People with serious lung conditions and difficulty breathing, bladder problems or seizures

should tell their doctor before using ARICEPT. ARICEPT 23 mg/day is associated with weight loss. Check with the

doctor if this is a concern. Inform the doctor if the patient needs surgery requiring anesthesia while taking ARICEPT.

Some people may have nausea, diarrhea, difficulty sleeping, vomiting or muscle cramps. Incidence of nausea and

vomiting were markedly greater in patients taking ARICEPT 23 mg/day versus patients taking ARICEPT 10 mg/day.

Some people may feel tired or may have loss of appetite. If they persist, please talk to the doctor.

The ARICEPT Patient Assistance Program can help qualified indigent and uninsured patients obtain ARICEPT at

no cost. Assistance is also available to Medicare Part D-insured patients who are in the coverage gap or donut hole.

To learn more and receive an application for assistance, please contact us Monday-Friday from 9 AM to 6 PM ET at:

Phone: 1-800-226-2072, Fax: 1-800-226-2059.

P l e a s e s e e im p o r t a n t P a t i e n t I n fo r m a t io n o n n e x t p a g e .

F o r m o r e in fo r m a t io n ,

v is it a r i c e p t . c o m

o r c a ll

8 6 6

- A R I C E P T .

You are encouraged to report negative side effects to the FDA. Visit fda.gov/medwatch

or call 1-800-FDA-1088.

^ > < 9